AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
190.07
+5.47 (2.96%)
At close: May 12, 2025, 4:00 PM
189.80
-0.27 (-0.14%)
Pre-market: May 13, 2025, 7:26 AM EDT
AbbVie Stock Forecast
Stock Price Forecast
According to 22 professional analysts, the 12-month price target for AbbVie stock ranges from a low of $185 to a high of $250. The average price target of $212 forecasts a 11.54% increase in the stock price over the next year.
Price Target: $212.00 (+11.54%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 8 | 8 | 8 | 8 |
| Buy | 11 | 11 | 11 | 10 | 10 | 11 |
| Hold | 2 | 3 | 3 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 21 | 21 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $214 → $216 | Strong Buy | Maintains | $214 → $216 | +13.64% | Apr 29, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $204 → $205 | Buy | Maintains | $204 → $205 | +7.86% | Apr 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $241 → $250 | Buy | Maintains | $241 → $250 | +31.53% | Apr 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $210 | Buy | Initiates | $210 | +10.49% | Apr 22, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $214 | Strong Buy | Reiterates | $214 | +12.59% | Apr 17, 2025 |
Financial Forecast
Revenue This Year
60.72B
from 56.33B
Increased by 7.79%
Revenue Next Year
65.53B
from 60.72B
Increased by 7.92%
EPS This Year
12.46
from 2.39
Increased by 421.27%
EPS Next Year
14.18
from 12.46
Increased by 13.79%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 63.6B | 70.0B | 75.0B | ||
| Avg | 60.7B | 65.5B | 69.9B | ||
| Low | 57.5B | 60.4B | 64.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.9% | 15.2% | 14.4% | ||
| Avg | 7.8% | 7.9% | 6.7% | ||
| Low | 2.1% | -0.5% | -1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.23 | 15.81 | 18.01 | ||
| Avg | 12.46 | 14.18 | 15.65 | ||
| Low | 11.77 | 12.58 | 13.54 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 453.6% | 26.9% | 27.0% | ||
| Avg | 421.3% | 13.8% | 10.4% | ||
| Low | 392.5% | 1.0% | -4.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.